trilliondollar

200~400% GROWTH

看多
NASDAQ:ECOR   electroCore, Inc.
Amazing product gammaCore (nVNS technology) that is FDA approved for certain treatments. At the moment it's a medical device painkiller without the use of medication/drug. Helps avoid many drug-like side effects and inconveniences associated with injectable, inhaled, or pill-based medicines.

The same product and technology is being extended to explore other areas:
www.electrocore.com/...velopments/pipeline/

Other Positives:

Positive financial guidance for next quarter:
Full-year 2020 Revenue: electroCore anticipates that full-year 2020 revenue will be at the upper end of the previously announced guidance range of $3.3 million to $3.5 million, representing greater than 40% growth over full-year 2019 revenue of $2.4 million.
(www.globenewswire.co...ancial-Guidance.html)
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。